Cannabis Employment Protections in Connecticut

This is not legal advice

This article is general information, not legal advice. Cannabis employment law in Connecticut is new, actively litigated, and changes at both the state and federal level. If you are facing discipline, termination, or a hiring decision tied to cannabis, talk to a Connecticut-licensed employment attorney. Information here was last verified in June 2024.

The statute at a glance

The Responsible and Equitable Regulation of Adult-Use Cannabis Act (RERACA), Public Act 21-1, was signed by Governor Ned Lamont on June 22, 2021 ^[1][2]. The employment provisions took effect July 1, 2022 and are codified primarily at Conn. Gen. Stat. § 31-51tt through § 31-51aaa ^[3].

The core rules for most private employers with at least one Connecticut employee:

• Pre-employment: An employer generally may not refuse to hire someone solely because a pre-employment drug test detected cannabis, unless the employer gave written notice at the time of application that a positive test could disqualify the applicant, or the position falls within an exempted category ^[3][4].
• Current employees: An employer generally may not fire, discipline, or otherwise penalize an employee for using cannabis outside of work hours and off the employer's premises, absent a written policy meeting statutory requirements ^[3][4].
• Written policy safe harbor: Employers who adopt a compliant written policy prohibiting cannabis use — and distribute it to employees before implementation — retain broad authority to test and discipline ^[3].

Strong evidence The statute exists and reads as described; how courts will interpret ambiguous terms like "impairment" is still developing.

Who is exempt

The exemptions in § 31-51tt(b) are extensive. Employees and applicants in the following categories are not protected by the off-duty use and pre-employment testing rules ^[3][4]:

• Firefighters and police officers
• Emergency medical technicians and paramedics
• Positions requiring a commercial driver's license (CDL)
• Positions requiring supervision or care of children, medical patients, or vulnerable persons
• Positions with the potential to adversely impact the health or safety of employees or the public
• Construction and mining trades
• Operators of motor vehicles, machinery, or power tools
• Positions funded wholly or in part by a federal grant
• Positions requiring completion of a federal background investigation or security clearance
• Positions in which the employer would violate a federal contract or lose federal funding

The "health or safety" and "federal funding" carve-outs are broad and, in practice, cover a large share of Connecticut jobs — including much of healthcare, education, transportation, and any employer with a federal contract subject to the Drug-Free Workplace Act ^[5]. Strong evidence

What employers can still do

Even for non-exempt positions, RERACA preserves substantial employer authority ^[3]:

• Prohibit use, possession, and impairment at work. The law does not require employers to tolerate on-the-job cannabis use or an employee who shows up impaired.
• Test based on reasonable suspicion of impairment. Employers may drug test if they have reasonable suspicion the employee is under the influence at work, or following a workplace accident.
• Random testing where already permitted by law (for example, DOT-regulated positions) is unchanged.
• Discipline for articulable symptoms of impairment. The statute lists example symptoms — decreased performance, disruption of a production process, carelessness resulting in injury, etc. — that can justify action ^[3].
• Adopt a zero-tolerance policy meeting the statutory notice requirements.

One quirk: because cannabis metabolites can be detected in urine for days or weeks after use, a positive test alone does not establish current impairment. Connecticut's statute recognizes this by requiring "articulable symptoms" rather than test results alone as the basis for impairment-based discipline in non-exempt roles ^[3][6]. Strong evidence

Medical cannabis is a separate track

Connecticut has protected registered medical marijuana patients from employment discrimination since 2012 under the Palliative Use of Marijuana Act (PUMA), Conn. Gen. Stat. § 21a-408p(b)(3) ^[7]. In Noffsinger v. SSC Niantic Operating Co. (D. Conn. 2018), a federal court held that PUMA's anti-discrimination provision is not preempted by the federal Controlled Substances Act, and awarded summary judgment to a job applicant whose offer was rescinded after a positive THC test ^[8]. This remains one of the most-cited decisions nationally on medical cannabis workplace rights. Strong evidence

Medical patients therefore have a somewhat stronger and older set of protections than adult-use consumers, though the same safety-sensitive and federal-nexus limits generally apply.

Remedies and enforcement

An aggrieved applicant or employee can sue in Connecticut Superior Court within 90 days of the alleged violation ^[3]. Available remedies include reinstatement, back wages, and reasonable attorney's fees. There is no administrative agency filing prerequisite comparable to a CHRO or EEOC charge for these specific claims, though related discrimination theories may still route through those agencies. Strong evidence

As of mid-2024, there is limited published Connecticut appellate case law interpreting the adult-use provisions specifically. Expect the contours — especially what counts as a "safety-sensitive" position and what a compliant written policy must contain — to be shaped by litigation over the next several years. Weak / limited

Practical guidance

If you are an employee or applicant:

• Ask for and read your employer's written drug and cannabis policy before assuming you are protected.
• Check whether your job falls into any exempt category — CDL, healthcare, childcare, construction, federal contractor, etc.
• Do not use cannabis at work or come to work impaired. The law does not protect this.
• If you are a registered medical patient, keep your registration current; PUMA protections are stronger.

If you are an employer:

• Review and update your written drug policy to meet the notice requirements of § 31-51tt.
• Train managers on documenting articulable symptoms of impairment rather than relying on test results alone.
• Map which positions genuinely qualify for exempt status and document the reasoning. Overclaiming "safety-sensitive" is a litigation risk.

See also: Cannabis Drug Testing, THC Metabolite Detection Windows, Medical Cannabis Patient Rights.

Sources

How this page was made